Nobel Prize Honors Light-Controlled Brain Research

The 2026 Nobel Prize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel for discoveries that established the foundations of optogenetics, a revolutionary technology that uses light to control specific nerve cells. Their work has enabled scientists to study how neural circuits shape memories, feelings and behaviour in the living brain with unprecedented precision.

The laureates were announced on Monday, October 5, in Stockholm, marking the beginning of the 2026 Nobel Prize announcements. According to the official schedule, prizes in the remaining categories will be announced through October 12.

The Nobel Committee recognised Deisseroth, Hegemann and Nagel for their discoveries concerning light-gated ion channels and optogenetics. Their work made it possible to use light to control the electrical activity of specific nerve cells.

Peter Hegemann and Georg Nagel laid a crucial foundation for the field by discovering the light-sensitive protein channelrhodopsin in the single-celled alga Chlamydomonas. When exposed to blue light, the protein opens a channel through which charged ions flow, generating an electrical signal in the cell. The researchers also found that introducing the protein into other cells could make those cells sensitive to light.

Karl Deisseroth transformed that discovery into a powerful neuroscience tool. He introduced the gene for channelrhodopsin into rat nerve cells and used blue light to trigger neural signals. He published the breakthrough in 2005 and, in 2007, demonstrated that the light-controlled switch could operate in the brains of living mice.

The resulting technology became known as optogenetics. Researchers can now activate or deactivate selected neural circuits with light, allowing them to investigate links between brain activity, memories, emotions and behaviour. The technology is also being used in research on neurological and psychiatric disorders, including schizophrenia, Alzheimer’s disease, Parkinson’s disease, epilepsy and addiction. Researchers are also exploring clinical applications such as restoring vision.

The Karolinska Institute said optogenetics has fundamentally changed brain research. Earlier methods often allowed scientists to map which brain regions were associated with particular functions, but they had limited ability to establish direct causal relationships. Optogenetics provides a way to control selected nerve cells with light and investigate those relationships more precisely.

The Medicine Nobel was the first prize announced in the 2026 Nobel Week. The Physics prize is scheduled for October 6, Chemistry for October 7, Literature for October 8, the Peace Prize for October 9 and the Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel for October 12.

The Nobel Prize in Physiology or Medicine has been awarded since 1901. Including the 2026 prize, the category has now been awarded 117 times to 234 laureates.

German scientist Emil von Behring became the first Medicine Nobel laureate in 1901 for his work on serum therapy against diphtheria.

Frederick G. Banting was the youngest Medicine Nobel laureate when he received the prize in 1923 for discoveries related to insulin, at the age of 32. Peyton Rous remains the oldest Medicine laureate, receiving the prize in 1966 at the age of 87.

The Nobel Prizes were first awarded in 1901 in accordance with Alfred Nobel’s will. The economics prize was added in 1969. The formal Nobel Prize award ceremony is held each year on December 10, the anniversary of Alfred Nobel’s death.

In 2026, each Nobel Prize carries a monetary award of 12 million Swedish kronor, along with a Nobel medal and diploma.

//DBTech/ASN/DPO/SMP//